Posts and Stories
Reverba Completes Acquisition of Six Degrees Worldwide to Unite Science and the Patient Voice to Advance Healthcare
SEATTLE, WA – Reverba, renowned for its innovative patient engagement solutions for biopharmaceutical companies, today announced the acquisition of Six Degrees Worldwide Inc., a leader in medical communications within the same industry. The acquisition is poised to help Reverba and its clients continue to bridge the gap between science and real-life patient experiences. Reverba’s acquisition will…
Read MoreHBA Rising Star: Crystal Anderson
By: Cheryl Lubbert We’re thrilled to announce the Healthcare Businesswomen’s Association (HBA) recently named Crystal Anderson, MPH, VP, Client Partner Lead as one of its 2024 Rising Stars. Crystal joins a noteworthy group of healthcare professionals recognized for their leadership and significant contributions to their organization – all in the first 15 to 20 years…
Read MoreTreatments for All: The Importance of Diversity in Clinical Trial Enrollment
By: Scott Lerman, VP, Partnerships Lead We start, as many stories do, with a personal anecdote. I love this photo. It’s of my grandmother and my father, taken at my Bar Mitzvah more than 40 years ago. Our family lore ultimately deemed this day my grandmother’s “last good day.” She passed away a little less…
Read More“The secret to successful patient influencer marketing? Authenticity”
Published in pharmaphorum By: Cheryl Lubbert, Co-Founder and CEO Reverba It may not be as straightforward as it is in the realms of fast fashion or tourism, but influencer marketing, especially on social media, is still an attractive avenue in the pharma world. Pharma companies strive to connect with patients, and what better way to…
Read MoreReverba CEO and Co-Founder Cheryl Lubbert Wins 2023 Silver Stevie® Award for Women in Business
– Awards recognize female entrepreneurs, executives and employees who are making positive contributions to their workplace and to the greater community – SEATTLE, WA, Nov. 13, 2023 – Reverba, a leading global patient engagement company, today announced that Cheryl Lubbert, Chief Executive Officer, has won the Silver Stevie® Award for Women in Business in the Mentor of the Year…
Read MoreSurvey: 3 Surprising Things BioPharma Can Learn about Patients’ Perceptions
By Jean McCoy Reverba EVP, Partnerships Perception is reality, as the saying goes. But sometimes, we can be too entrenched in our daily routine, entrenched in our field, and we can miss key factors that could change the way we think about what we do day to day. We recently conducted two parallel surveys that,…
Read MoreAuthenticity In An Automated World: Surprising Guidance From Healthcare
Published in Forbes By: Cheryl Lubbert, Forbes Councils Member When faced with online customer service “agents” who don’t have real answers or solutions for specific problems, email responses that don’t sound quite human and videos that could be deceptive altered deepfakes, consumers increasingly have questions about what is real. In a world of growing automation…
Read MoreEmbrace the Rainbow: Three Tips to Make DEI Foundational In Your Clinical Program
By: Jean McCoy Diversity in clinical trials is a hot-button topic, with attention and programs ranging from legislation (both proposed and passed) to industry conference panels and required continuing education for healthcare professionals. While these initiatives usually address “underrepresented communities,” in practice, they often refer to increasing participation among racial and ethnic groups. During Pride…
Read MoreThe Patient Voice: Industry and Advocates Speak in Harmony
By: Jean McCoy A generation ago, HIV/AIDS patients had to “Act Up” to be heard. A recent virtual summit shows how much has changed since the days of that pioneering patient advocacy group. At the Global Innovation in Patient Advocacy conference, one theme echoed throughout multiple presentations by patient advocates and industry representatives alike: it’s important to…
Read MoreHow Can We Have More Successful Rare Disease Trials?
By: Reverba Clinical Partnerships Team More than 300 million people around the world live with a rare disease—that is, a condition that affects fewer than 1 in 2,000. Although each of these estimated 5,000 to 7,000 or more rare diseases affects a relatively small number of individuals, the impact on those patients’ lives is significant.…
Read More